All Cosmos Bio-Tech Holding Corp (4148)

Currency in TWD
45.10
+0.15(+0.33%)
Closed·

4148 Financial Summary

Key Ratios

P/E Ratio23.74
Price/Book1.06
Debt / Equity8.2%
Return on Equity5.18%
Dividend Yield1.11%
EBITDA199.16M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of TWD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.77%
Dividend Yield
1.10%
Industry Median 2.88%
Annualised payout
0.50
Paid annually
5-Years Growth
-12.94%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
547.93M / --
EPS Revisions
Last 90 days

FAQ

What were All Cosmos Bio-Tech's earnings for the latest quarter?

The All Cosmos Bio-Tech EPS (TTM) is 1.77. All Cosmos Bio-Tech reported sales of 547.93, net income of 13.07, and EPS of 0.20 for the latest quarter.

What was All Cosmos Bio-Tech's net income for the latest quarter?

All Cosmos Bio-Tech's net income for the latest quarter was 13.07.

How did All Cosmos Bio-Tech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 710.41 in the previous quarter to 547.93 in the latest quarter, and net income moved from 20.03 to 13.07 compared to the previous quarter.

What is All Cosmos Bio-Tech's net profit margin on a TTM basis?

All Cosmos Bio-Tech's trailing twelve months (TTM) net profit margin is 5.23%.

How does All Cosmos Bio-Tech's debt to equity ratio compare to industry standards?

All Cosmos Bio-Tech's total debt-to-equity ratio is 8.20%.

What is All Cosmos Bio-Tech's return on investment on a TTM basis?

All Cosmos Bio-Tech's trailing twelve months (TTM) return on investment (ROI) is 5.18%.

Did All Cosmos Bio-Tech gain or lose cash last quarter?

In the latest quarter, All Cosmos Bio-Tech's net change in cash was -7.88 million.

What were All Cosmos Bio-Tech's total assets and liabilities in the latest quarter?

As of the latest quarter, All Cosmos Bio-Tech reported total assets of 3,709.20 million and total liabilities of 481.11 million.

How has All Cosmos Bio-Tech's total revenue grown this year?

All Cosmos Bio-Tech's total revenue was 710.41 in the previous quarter and 547.93 in the latest quarter.

What is All Cosmos Bio-Tech's gross margin on a TTM basis?

All Cosmos Bio-Tech's trailing twelve months (TTM) gross margin is 27.80%.

What was All Cosmos Bio-Tech's revenue per share for the latest quarter?

All Cosmos Bio-Tech's revenue per share for the latest quarter was 32.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.